Literature DB >> 8048242

Preventing bone disease requires diligent management in patients with renal failure.

F O Kolb.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8048242      PMCID： PMC1022503     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  20 in total

Review 1.  Citrate: a major factor in the toxicity of orally administered aluminum compounds.

Authors:  B A Molitoris; D H Froment; T A Mackenzie; W H Huffer; A C Alfrey
Journal:  Kidney Int       Date:  1989-12       Impact factor: 10.612

Review 2.  Posttransplantation bone disease.

Authors:  I A Katz; S Epstein
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

3.  Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis.

Authors:  M Fukagawa; R Okazaki; K Takano; S Kaname; E Ogata; M Kitaoka; S Harada; N Sekine; T Matsumoto; K Kurokawa
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

Review 4.  Osteomalacia and bone disease arising from aluminum.

Authors:  J W Coburn; K C Norris; H G Nebeker
Journal:  Semin Nephrol       Date:  1986-03       Impact factor: 5.299

5.  Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.

Authors:  D L Andress; K C Norris; J W Coburn; E A Slatopolsky; D J Sherrard
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

Review 6.  Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease.

Authors:  J A Delmez; E Slatopolsky
Journal:  Am J Kidney Dis       Date:  1992-04       Impact factor: 8.860

7.  Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy.

Authors:  Q Y Duh; R C Lim; O H Clark
Journal:  Arch Surg       Date:  1991-10

Review 8.  Musculoskeletal complications after renal transplantation: pathogenesis and treatment.

Authors:  B A Julian; L D Quarles; K M Niemann
Journal:  Am J Kidney Dis       Date:  1992-02       Impact factor: 8.860

9.  The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.

Authors:  A J Brown; C R Ritter; J L Finch; J Morrissey; K J Martin; E Murayama; Y Nishii; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

10.  Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia.

Authors:  R O'Donovan; D Baldwin; M Hammer; C Moniz; V Parsons
Journal:  Lancet       Date:  1986-04-19       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.